Thrombosis and Haemostasis, Inhaltsverzeichnis Thromb Haemost 2008; 99(01): 64-70DOI: 10.1160/TH07-07-0438 Blood Coagulation, Fibrinolysis and Cellular Haemostasis Schattauer GmbH Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding Authors Institutsangaben Saskia E. M Schols 1 Department of Biochemistry (CARIM), Maastricht University 2 Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands Paola E. J. van der Meijden 1 Department of Biochemistry (CARIM), Maastricht University René van Oerle 1 Department of Biochemistry (CARIM), Maastricht University 2 Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands Joyce Curvers 3 Catharina Hospital, Eindhoven, The Netherlands Johan W. M Heemskerk 1 Department of Biochemistry (CARIM), Maastricht University Elisabeth C. M. van Pampus 2 Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands Artikel empfehlen Abstract Volltext als PDF herunterladen(opens in new window) Keywords KeywordsBleeding - dilutional coagulopathy - fibrinogen - platelets - thrombin generation Referenzen References 1 Johansson PI, Hansen MB, Sorensen H. Transfusion practice in massively bleeding patients: time for a change?. Vox Sang 2005; 89: 92-96. 2 Stanworth SJ, Brunskill SJ, Hyde CJ. et al. Is fresh frozen plasma clinically effective?. Br J Haematol 2004; 126: 139-152. 3 Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005; 89: 123-127. 4 Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10. 5 Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion. The effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-139. 6 Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 2005; 95: 130-139. 7 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90. 8 Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements. An update on monitoring haemostatic response using thromboelastography. Haemophilia 2005; 11: 1-6. 9 Barrowcliffe TW. Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A. Haemophilia 2006; 12 S4: 23-29. 10 Nieuwenhuys CMA, Feijge MAH, Béguin S. et al. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma. Thromb Haemost 2000; 84: 1045-1051. 11 Vanschoonbeek K, Feijge MAH, Paquay M, Rosing J, Saris W, Kluft C. et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 2004; 24: 1734-1740. 12 Matthes GA. Options and cost effectiveness of multicomponent blood collection. Transfus Apher Sci 2002; 27: 115-121. 13 O’Shaughnessy DF, Atterbury C, Bolton Maggs P. et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28. 14 Chowdhury P, Saayman AG, Paulus U. et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73. 15 Hemker HC, Giesen P, Al Dieri R. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15. 16 Rosing J, Tans G, Govers-Riemslag JW. et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283. 17 Vanschoonbeek K, Feijge MAH, van Kampen RJ, Kenis H, Hemker HC, Giesen PLA. et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma. J Thromb Haemost 2004; 2: 476-484. 18 Van der Meijden PEJ, Feijge MAH, Giesen PLA. et al. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost 2005; 93: 1128-1136. 19 Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-1285. 20 Al Dieri R, Alban S, Béguin S. et al. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J Thromb Haemost 2004; 2: 1395-1401. 21 Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2006; 53: S40-S58. 22 Hemker HC, Al Dieri R, de Smedt E. et al. Thrombin generation, a function test of the haemostaticthrombotic system. Thromb Haemost 2006; 96: 553-561. 23 Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-193. 24 Fries D, Haas T, Klingler A. et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy, a porcine model. Br J Anaesth 2006; 97: 460-467. 25 Kheirabadi BS, Crissey JM, Deguzman R. et al. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007; 62: 1352-1359.
